NARIUnknown

Inari Medical, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Inari Medical, Inc. (NARI), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are NARI insiders buying or selling?

Inari Medical, Inc. insiders reported 13 open-market buys ($25.9M) and 203 sells ($583.3M) across 216 Form 4 filings — a net selling position of $557.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jan 9, 2025)

Total Form 4 filings
216
SEC EDGAR
Insider filers
12
Insider buys (13)
$25.9M
Insider sells (203)
$583.3M

Insider sentiment

Net selling

Net insider flow of $557.4M in net selling.

Recent NARI insider transactions

DateInsiderRoleTypeSharesPriceValue
Jan 9, 2025William HoffmanDirectorSale200.0K$60.47$12.1M
Dec 21, 2024Andrew HykesPresident and CEOSale3.0K$55.29$165.9K
Dec 18, 2024William HoffmanDirectorSale60.0K$55.66$3.3M
Dec 12, 2024Thomas TuChief Medical OfficerSale4.0K$55.00$220.0K
Nov 22, 2024Andrew HykesPresident and CEOSale3.0K$50.83$152.5K
Nov 20, 2024William HoffmanDirectorSale60.0K$51.16$3.1M
Oct 31, 2024Andrew HykesPresident and CEOSale3.0K$50.00$150.0K
Oct 31, 2024William HoffmanDirectorSale40.0K$50.05$2.0M
Oct 18, 2024William HoffmanDirectorSale40.0K$45.02$1.8M
Sep 18, 2024William HoffmanDirectorSale40.0K$45.83$1.8M
Sep 13, 2024Mitch C. Hill,Chief Financial OfficerSale3.0K$45.13$135.4K
Aug 22, 2024Andrew HykesPresident and CEOSale3.0K$50.00$150.0K
Aug 20, 2024William HoffmanDirectorSale60.0K$49.36$3.0M
Aug 14, 2024Mitch C. Hill,Chief Financial OfficerSale5.0K$47.99$240.0K
Jul 24, 2024Andrew HykesPresident and CEOSale3.0K$55.23$165.7K
Jul 18, 2024William HoffmanDirectorSale60.0K$56.74$3.4M
Jul 18, 2024Thomas TuChief Medical OfficerSale3.5K$55.16$192.0K
Jul 16, 2024Thomas TuChief Medical OfficerSale16.5K$55.09$910.1K
Jul 16, 2024Mitch C. Hill,Chief Financial OfficerSale5.0K$53.95$269.8K
Jul 3, 2024William HoffmanDirectorSale20.0K$50.15$1.0M
Jul 3, 2024Andrew HykesPresident and CEOSale3.0K$50.08$150.2K
Jun 24, 2024Rebecca ChambersDirectorSale260$45.99$12.0K
Jun 20, 2024William HoffmanDirectorSale40.0K$43.54$1.7M
Jun 14, 2024Mitch C. Hill,Chief Financial OfficerSale5.0K$47.60$238.0K
May 31, 2024MILDER DONALD BDirectorPurchase56.1K$53.44$3.0M

Showing the 25 most recent of 216 Form 4 filings for Inari Medical, Inc..

Most active NARI insiders

  • William Hoffman62 filings
  • Mitch C. Hill,44 filings
  • Andrew Hykes39 filings
  • Thomas Tu28 filings
  • MILDER DONALD B26 filings

Ask anything about NARI insider activity

Use Trabud's AI agent to query Inari Medical, Inc.'s Form 4 history in plain English — "Show me NARI CEO purchases this year" or compare it against any other ticker.

Open the AI agent

NARI insider trading FAQ

Are Inari Medical, Inc. insiders buying or selling?

Across 216 SEC Form 4 filings, Inari Medical, Inc. (NARI) insiders reported 13 open-market purchases totaling $25.9M and 203 sales totaling $583.3M. That is a net selling position of $557.4M.

How many insiders trade NARI stock?

12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Inari Medical, Inc.. The most recent filing was accepted on Jan 9, 2025.

Where does Trabud get NARI insider trading data?

All NARI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content